NAII

Business Context and Reporting Period

Company: Natural Alternatives International, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and six months ended December 31, 2001 (Fiscal 2002)
Business Overview: The Company manufactures and distributes dietary supplements, vitamins, and nutritional products. Operations are primarily located in San Marcos, California, with a manufacturing subsidiary in Switzerland.

Key Financial Metrics

Note: Debt figures derived from Balance Sheet lines for Lines of Credit, Current installments of long-term debt, and Long-term debt.

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 12.6% in the quarter and 5.0% for the six-month period compared to the prior year, driven by an existing major customer and new direct-to-consumer (DTC) product introductions.
• Profitability Decline: Despite revenue growth, the Company reported a net loss of $594,000 for the six months ended Dec 31, 2001, compared to a net income of $648,000 in the prior year period. Operating income turned negative ($185,000 loss) for the six-month period.
• Expense Increases: Selling, General & Administrative (SG&A) expenses rose 35% year-over-year for the six-month period. This was primarily due to $800,000 in incremental DTC promotional/fulfillment costs, $300,000 in legal costs, and $150,000 in employee separation expenses.
• Margin Compression: Gross margin decreased to 21.4% in the quarter from 23.6% in the prior year quarter, attributed to increased raw material costs and product mix changes.
• Liquidity: Working capital decreased by approximately $711,000 from June 30, 2001, due to increased borrowings and accounts payable, partially offset by higher receivables and inventory.

Guidance, Outlook, and Risks

• Management Commentary: Management expects operating results to fluctuate. They anticipate that costs related to the transition of the DTC call center and fulfillment operations will remain elevated or increase in the near term.
• Financing: In October 2001, the Company amended its credit agreement, reducing the maximum borrowing limit to $2.5 million and increasing interest rates to prime plus 3.5%. The agreement expires July 1, 2002. The Company was in compliance with covenants as of Dec 31, 2001.
• Legal Contingencies:
  • Antitrust Litigation: The Company is a plaintiff in In re: Vitamin Antitrust Litigation. A settlement payment of approximately $1.0 million was received subsequent to Dec 31, 2001. No assurance is given regarding remaining claims.
  • Executive Lawsuit: A lawsuit filed by a former President/CFO was settled in November 2001 with no further economic obligations to the Company.
• Risk Factors:
  • Customer Concentration: Three customers accounted for 74% of net sales for the six months ended Dec 31, 2001. Loss of any major customer would have a material adverse impact.
  • Stock Price Volatility: The stock price is near historic lows, and future profitability is not assured.
  • Regulatory Environment: Operations are subject to FDA and FTC regulations regarding dietary supplements, which could lead to recalls or reformulations.

Investor Verification Checklist

• Customer Concentration: Verify the stability of the top three customers who represent 74% of revenue.
• DTC Cost Structure: Assess whether the high SG&A costs associated with the new DTC channel are sustainable or if the new fulfillment center will reduce expenses as projected.
• Debt Covenants: Monitor compliance with the amended credit agreement covenants, particularly given the recent net loss and reduced borrowing capacity.
• Antitrust Settlement: Confirm the finality and total value of the Vitamin Antitrust Litigation settlement received post-period.
• Inventory Levels: Review inventory turnover given the increase in raw materials and finished goods, which could indicate overstocking or demand shifts.